Patent trickery


Patent trickery

On 14 November the High Court granted an interim interdict in favour of pharmaceutical giant Bayer, preventing the generic manufacturer Pharma Dynamics from selling an oral contraceptive called Ruby. Big pharma is using South Africa's weak intellectual property laws to inject extra life into its drugs monopoly. And we see that healthcare regulations benefit monopolies, rather than the public.

Like to see more ?


Subscribe to our on-line edition !

For a mere R305.00 per year you get the convenience of our online version including:
  • Twelve monthly issues of Noseweek delivered to your browser
  • A searchable archive
  • Access to every back issue since 1993 !
  • A downloadable PDF version

If it’s just the article you are after, you can purchase it by clicking here.

Tempted ?


For a taste of what awaits you, you are welcome to browse this free issue.

Share this article:

Reader's comments

Like to add your own comment ? Please click here to subscribe - OR -

Disclaimer

While every reasonable effort is taken to ensure the accuracy and soundness of the contents of this publication, neither the authors nor the publishers of this website bear any responsibility for the consequences of any actions based on the information contained therein.